Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Alpha-methyltryptamine sulfonamide derivatives as novel glucocorticoid receptor ligands.

Marshall DR, Rodriguez G, Thomson DS, Nelson R, Capolina A.

Bioorg Med Chem Lett. 2007 Jan 15;17(2):315-9. Epub 2006 Oct 25.

PMID:
17118655
2.

Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.

Takahashi H, Bekkali Y, Capolino AJ, Gilmore T, Goldrick SE, Nelson RM, Terenzio D, Wang J, Zuvela-Jelaska L, Proudfoot J, Nabozny G, Thomson D.

Bioorg Med Chem Lett. 2006 Mar 15;16(6):1549-52. Epub 2005 Dec 28.

PMID:
16386422
3.

Function-regulating pharmacophores in a sulfonamide class of glucocorticoid receptor agonists.

Kuzmich D, Bentzien J, Betageri R, DiSalvo D, Fadra-Khan T, Harcken C, Kukulka A, Nabozny G, Nelson R, Pack E, Souza D, Thomson D.

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6640-4. doi: 10.1016/j.bmcl.2013.10.052. Epub 2013 Oct 31.

PMID:
24215891
4.

Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.

Roach SL, Higuchi RI, Adams ME, Liu Y, Karanewsky DS, Marschke KB, Mais DE, Miner JN, Zhi L.

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3504-8. doi: 10.1016/j.bmcl.2008.05.029. Epub 2008 May 11.

PMID:
18513967
5.

Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.

Ettaoussi M, Péres B, Klupsch F, Delagrange P, Boutin JA, Renard P, Caignard DH, Chavatte P, Berthelot P, Lesieur D, Yous S.

Bioorg Med Chem. 2008 May 1;16(9):4954-62. doi: 10.1016/j.bmc.2008.03.036. Epub 2008 Mar 17.

PMID:
18372181
6.

Non-steroidal steroid receptor modulators.

Hermkens PH, Kamp S, Lusher S, Veeneman GH.

IDrugs. 2006 Jul;9(7):488-94. Review.

PMID:
16821162
7.

Design of ligands for the glucocorticoid and progestin receptors.

Teutsch G, Gaillard-Moguilewsky M, Lemoine G, Nique F, Philibert D.

Biochem Soc Trans. 1991 Nov;19(4):901-8. No abstract available.

PMID:
1794581
8.

Tryptamine-based human beta3-adrenergic receptor agonists. Part 2: SAR of the methylene derivatives.

Sawa M, Tateishi H, Mizuno K, Harada H, Oue M, Tsujiuchi H, Furutani Y, Kato S.

Bioorg Med Chem Lett. 2004 Dec 20;14(24):5963-6.

PMID:
15546708
9.

High-throughput synthesis optimization of sulfonamide NPY Y5 antagonists.

Finn J, Pelham D, Walker MW, Gluchowski C.

Bioorg Med Chem Lett. 2002 Jul 8;12(13):1771-4.

PMID:
12067558
10.

Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands.

Rupprecht R, Reul JM, van Steensel B, Spengler D, Söder M, Berning B, Holsboer F, Damm K.

Eur J Pharmacol. 1993 Oct 15;247(2):145-54.

PMID:
8282004
11.

N-arylsulfonyl-2-vinyltryptamines as new 5-HT6 serotonin receptor ligands.

Raoul M, Patigny D, Fabis F, Dauphin F, Rault S, Sapi J, Laronze JY.

J Enzyme Inhib Med Chem. 2006 Jun;21(3):251-60.

PMID:
16918072
12.

Structure-activity relationship of benzo[b]thiophene-2-sulfonamide derivatives as novel human chymase inhibitors.

Masaki H, Mizuno Y, Tatui A, Murakami A, Koide Y, Satoh S, Takahashi A.

Bioorg Med Chem Lett. 2003 Nov 17;13(22):4085-8. Erratum in: Bioorg Med Chem Lett. 2004 Apr 5;14(7):1817.

PMID:
14592513
13.

Synthesis and preliminary screening of novel tryptamines as 5-HT4 receptor ligands.

Hanna-Elias A, Manallack DT, Berque-Bestel I, Irving HR, Coupar IM, Iskander MN.

Curr Med Chem. 2010;17(25):2775-87.

PMID:
20586717
14.

Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands.

Worm K, Zhou QJ, Saeui CT, Green RC, Cassel JA, Stabley GJ, DeHaven RN, Conway-James N, LaBuda CJ, Koblish M, Little PJ, Dolle RE.

Bioorg Med Chem Lett. 2008 May 1;18(9):2830-5. doi: 10.1016/j.bmcl.2008.04.006. Epub 2008 Apr 7.

PMID:
18430570
15.

Synthesis and evaluation of new arylsulfonamidomethylcyclohexyl derivatives as human neuropeptide Y Y5 receptor antagonists for the treatment of obesity.

Moreno A, Pérez S, Galiano S, Juanenea L, Erviti O, Frígola C, Aldana I, Monge A.

Eur J Med Chem. 2004 Jan;39(1):49-58.

PMID:
14987833
16.

Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonists.

Baker J, Bingham M, Blackburn-Munro R, Cai J, Craighead M, Gilfillan R, Goan K, Jaap D, Milne R, Morphy JR, Napier S, Presland J, Spinks G, Thomson F.

Bioorg Med Chem Lett. 2011 Jun 15;21(12):3603-7. doi: 10.1016/j.bmcl.2011.04.104. Epub 2011 May 1.

PMID:
21601454
17.

Discovery of a potent series of non-steroidal non α-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicity.

Diallo H, Angell DC, Barnett HA, Biggadike K, Coe DM, Cooper TW, Craven A, Gray JR, House D, Jack TI, Keeling SP, Macdonald SJ, McLay IM, Oliver S, Taylor SJ, Uings IJ, Wellaway N.

Bioorg Med Chem Lett. 2011 Feb 15;21(4):1126-33. doi: 10.1016/j.bmcl.2010.12.121. Epub 2010 Dec 31.

PMID:
21257309
18.

Identification of novel glycine sulfonamide antagonists for the EP1 receptor.

McKeown SC, Hall A, Blunt R, Brown SH, Chessell IP, Chowdhury A, Giblin GM, Healy MP, Johnson MR, Lorthioir O, Michel AD, Naylor A, Lewell X, Roman S, Watson SP, Winchester WJ, Wilson RJ.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1750-4. Epub 2006 Dec 22.

PMID:
17236765
19.

Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.

Ghosh AK, Kumaragurubaran N, Hong L, Kulkarni SS, Xu X, Chang W, Weerasena V, Turner R, Koelsch G, Bilcer G, Tang J.

J Med Chem. 2007 May 17;50(10):2399-407. Epub 2007 Apr 14.

PMID:
17432843
20.

Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8.

Jenkins TJ, Guan B, Dai M, Li G, Lightburn TE, Huang S, Freeze BS, Burdi DF, Jacutin-Porte S, Bennett R, Chen W, Minor C, Ghosh S, Blackburn C, Gigstad KM, Jones M, Kolbeck R, Yin W, Smith S, Cardillo D, Ocain TD, Harriman GC.

J Med Chem. 2007 Feb 8;50(3):566-84.

PMID:
17266208

Supplemental Content

Support Center